Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kabra Drugs Ltd held its Extra-Ordinary General Meeting (EGM) on 26th December 2025 at 09:00 AM at Ginger Hotel, Indore, Madhya Pradesh, and the meeting concluded at 09:30 AM. Five items of business were transacted: appointment of Ms. Ritu Tiwari (DIN: 11040362) and Ms. Nikita Sinha (DIN: 11126745) as non-executive independent directors, approval of remuneration payable to Mr. Kuniamuthur Nanjappan Anand, approval for making loans, guarantees, or investments under Section 186 and Section 185 of the Companies Act, 2013, and appointment of Mrs. Twinkle Agarwal as Secretarial Auditor for a 5-year term. The first four resolutions were passed as Special Resolutions and the fifth as an Ordinary Resolution. Voting was conducted through remote e-voting (23rd–25th December 2025) and physical ballot at the meeting, with M/s. Jay Jain & Associates appointed as Scrutinizer. The Chairperson stated that voting results would be announced within 48 hours and filed separately with the stock exchanges.
Shareholders approved key board and governance changes, including two new independent directors, a 5-year secretarial auditor appointment, executive remuneration, and expanded borrowing/investment authority under Section 186. The detailed voting results are still pending and will be filed separately, which investors should monitor for final approval margins.